| Literature DB >> 6441709 |
A L Barry, R N Jones, C Thornsberry, T L Gavan, E H Gerlach, H M Sommer.
Abstract
The in vitro activity of 3-0-demethyl fortimicin A was compared to that of amikacin and tobramycin against 5,230 clinical isolates in four institutions. Amikacin and tobramycin were more active than 3-0-demethyl fortimicin A against Pseudomonas aeruginosa and Acinetobacter spp., but all three drugs had similar activity against the Enterobacteriaceae and Staphylococcus aureus. Additional tests with 335 representative gram-negative bacilli compared five different aminoglycosides, demonstrating differences with some isolates. Standardized disk diffusion tests were also performed with 30 micrograms 3-0-demethyl fortimicin A disks, according to the National Committee for Clinical Laboratory Standards. The following interpretive breakpoints are proposed: less than or equal to 11 mm for resistant (MIC greater than or equal to 32 micrograms/ml) and greater than or equal to 15 mm for susceptible (MIC less than or equal to 16 micrograms/ml).Entities:
Mesh:
Substances:
Year: 1984 PMID: 6441709 DOI: 10.1007/bf02013613
Source DB: PubMed Journal: Eur J Clin Microbiol ISSN: 0722-2211 Impact factor: 3.267